Sowell Financial Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NAVB
BCM
ACM
Sowell Financial Services's NAVB Position: Q2 2021 in Review
Sowell Financial Services sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2021, closing a stake of 11,190 shares — an estimated $18K sold.
Sowell Financial Services first reported a position in NAVB in Q4 2016 and held it in 16 quarters. The position peaked at $714K in Q1 2017. 31 funds tracked by Wall St. Rank hold NAVB as of Q2 2021.
- Sowell Financial Services reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2021 after selling out during the quarter.
- Sowell Financial Services sold 11,190 Navidea Biopharmaceuticals Inc. shares in Q2 2021, an estimated $18K.
- Sowell Financial Services first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2016 and held it in 16 quarters.
- Sowell Financial Services's Navidea Biopharmaceuticals Inc. position peaked at $714K in Q1 2017.
- 31 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2021.
Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.